Literature DB >> 21629994

Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon.

Eiji Kusano1.   

Abstract

In Japan, the number of chronic kidney disease (CKD) patients is thought to be 13,300,000, next in size after those with hypertension and diabetes. Although the number of patients with CKD seems large, it does not mean that all these patients require special treatment. Among them, nephrologists should pay special attention to patients with glomerular filtration rate below 50 mL/min/1.73 m(2) and progressive deterioration of renal function. Treatment of these CKD patients by a limited number of specialists is simply impossible; hence, it is essential to request treatment from physicians who are involved in general internal medicine and primary care. It is well known that not only does CKD cause end-stage renal failure, it also causes the onset of cardiovascular diseases (CVD) such as cardiac infarction and cerebral stroke; however, the question is how much significance does CKD have as a risk factor for CVD. It is understandable that hypertension and CVD are often complications of CKD; however, in addition to what is conventionally mentioned, there are three or four mechanisms that we would like to emphasize, and discuss herein. Among them, we would like to stress the role of klotho genes with special reference to the generation of CVD in CKD patients. When patients develop CKD, it is therefore necessary to remove as far as possible any factors that could represent a risk for CVD. Moreover, by taking appropriate measures against clinical conditions that often complicate CKD, such as hypertension, renal anemia, hyperuricemia, and hyperlipidaemia, the development of CVD can be prevented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21629994     DOI: 10.1007/s10157-011-0461-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  40 in total

1.  Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.

Authors:  Yoshiyuki Morishita; Shiho Hanawa; Junko Chinda; Osamu Iimura; Sadao Tsunematsu; Eiji Kusano
Journal:  Hypertens Res       Date:  2010-12-02       Impact factor: 3.872

2.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

3.  Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.

Authors:  Marcello Tonelli; Frank Sacks; Marc Pfeffer; Zhiwei Gao; Gary Curhan
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

Review 4.  Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Authors:  Z H Israili; W D Hall
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

5.  Prevalence of chronic kidney disease in the Japanese general population.

Authors:  Enyu Imai; Masaru Horio; Tsuyoshi Watanabe; Kunitoshi Iseki; Kunihiro Yamagata; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Toshiki Moriyama; Yasuhiro Ando; Shoichi Fujimoto; Tsuneo Konta; Hitoshi Yokoyama; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-11       Impact factor: 2.801

6.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

7.  Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats.

Authors:  Ayinuer Adijiang; Sumie Goto; Satsuki Uramoto; Fuyuhiko Nishijima; Toshimitsu Niwa
Journal:  Nephrol Dial Transplant       Date:  2008-03-11       Impact factor: 5.992

Review 8.  Klotho.

Authors:  Makoto Kuro-o
Journal:  Pflugers Arch       Date:  2010-01       Impact factor: 3.657

9.  Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.

Authors:  T Fujita; K Ando; H Nishimura; T Ideura; G Yasuda; M Isshiki; K Takahashi
Journal:  Kidney Int       Date:  2007-10-17       Impact factor: 10.612

10.  Augmented Wnt signaling in a mammalian model of accelerated aging.

Authors:  Hongjun Liu; Maria M Fergusson; Rogerio M Castilho; Jie Liu; Liu Cao; Jichun Chen; Daniela Malide; Ilsa I Rovira; Daniel Schimel; Calvin J Kuo; J Silvio Gutkind; Paul M Hwang; Toren Finkel
Journal:  Science       Date:  2007-08-10       Impact factor: 47.728

View more
  9 in total

1.  The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients.

Authors:  Tetsu Akimoto; Kazuhiro Shiizaki; Taro Sugase; Yuko Watanabe; Hiromichi Yoshizawa; Naoko Otani; Akihiko Numata; Eri Takeshima; Tomoyuki Yamazaki; Takuya Miki; Chiharu Ito; Johanne V Pastor; Yoshitaka Iwazu; Osamu Saito; Shigeaki Muto; Makoto Kuro-o; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2012-02-18       Impact factor: 2.801

2.  Promoter methylation confers kidney-specific expression of the Klotho gene.

Authors:  Masahiro Azuma; Daisuke Koyama; Jiro Kikuchi; Hiromichi Yoshizawa; Dissayabutra Thasinas; Kazuhiro Shiizaki; Makoto Kuro-o; Yusuke Furukawa; Eiji Kusano
Journal:  FASEB J       Date:  2012-07-10       Impact factor: 5.191

3.  Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Chien-Te Lee; I-Wen Wu; Shou-Shan Chiang; Yu-Sen Peng; Kuo-Hsiung Shu; Ming-Ju Wu; Mai-Szu Wu
Journal:  J Nephrol       Date:  2014-05-20       Impact factor: 3.902

4.  Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy.

Authors:  Ke Yang; Cheng Wang; Ling Nie; Xiaohui Zhao; Jun Gu; Xu Guan; Song Wang; Tangli Xiao; Xinli Xu; Ting He; Xuefeng Xia; Junping Wang; Jinghong Zhao
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

5.  Serum uric acid levels and long-term outcomes in chronic kidney disease.

Authors:  Tokiko Miyaoka; Toshio Mochizuki; Takashi Takei; Ken Tsuchiya; Kosaku Nitta
Journal:  Heart Vessels       Date:  2013-08-09       Impact factor: 2.037

6.  Extreme ambient temperatures and cardiorespiratory emergency room visits: assessing risk by comorbid health conditions in a time series study.

Authors:  Eric Lavigne; Antonio Gasparrini; Xiang Wang; Hong Chen; Abderrahmane Yagouti; Manon D Fleury; Sabit Cakmak
Journal:  Environ Health       Date:  2014-02-03       Impact factor: 5.984

7.  Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study.

Authors:  Sylvie Perreault; Javier Nuevo; Scott Baumgartner; Robert Morlock
Journal:  World J Nephrol       Date:  2017-05-06

Review 8.  Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together.

Authors:  Sandro Marini; Marios K Georgakis; Christopher D Anderson
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

9.  Cystatin C predicts the risk of incident cerebrovascular disease in the elderly: A meta-analysis on survival date studies.

Authors:  Xin Zheng; Hong-da She; Qiao-Xin Zhang; Tong Si; Ku-Sheng Wu; Ying-Xiu Xiao
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.